Plexus Corp
PLXS138.460USD
+5.720+4.31%
Close 11/21, 16:00（ET）Quotes delayed by 15 min
3.71BMarket Cap
21.49P/E TTM
More Details of Plexus Corp Company
Plexus Corp. is focused on providing designing and developing, supplying chain solutions, new product introduction, manufacturing and sustaining services. It specializes in serving customers in industries with complex products and demanding regulatory environments. It offers life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, and innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. Its segments include Americas (AMER), Asia-Pacific (APAC) and Europe, Middle East, and Africa (EMEA) regions. Its design and development capabilities include mechanical engineering, electrical engineering, software engineering, quality and compliance engineering, and project management. Its supply chain capabilities include design for supply chain, supply chain risk management, and managing global, and complex supply chains.
Plexus Corp Info
Ticker SymbolPLXS
Company namePlexus Corp
IPO dateFeb 05, 1986
CEOMr. Todd P. Kelsey
Number of employees20000
Security typeOrdinary Share
Fiscal year-endFeb 05
AddressOne Plexus Way
CityNEENAH
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code54956
Phone19209696000
Websitehttps://www.plexus.com/en-us/
Ticker SymbolPLXS
IPO dateFeb 05, 1986
CEOMr. Todd P. Kelsey
Company Executives of Plexus Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Dean A. Foate
Mr. Dean A. Foate
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
128.06K
+1.57%
Mr. Todd P. Kelsey
Mr. Todd P. Kelsey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
70.15K
+9.25%
Mr. Michael V. (Mike) Schrock
Mr. Michael V. (Mike) Schrock
Lead Independent Director
Lead Independent Director
42.96K
+4.83%
Mr. Patrick John Jermain, CPA
Mr. Patrick John Jermain, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
23.97K
+6.31%
Dr. Joann M. Eisenhart, Ph.D.
Dr. Joann M. Eisenhart, Ph.D.
Independent Director
Independent Director
20.34K
+10.78%
Mr. Paul A. Rooke
Mr. Paul A. Rooke
Independent Director
Independent Director
14.62K
+15.65%
Ms. Karen Marie Rapp
Ms. Karen Marie Rapp
Independent Director
Independent Director
8.16K
-7.90%
Mr. Randy J. Martinez
Mr. Randy J. Martinez
Independent Director
Independent Director
4.83K
-15.51%
Mr. Michael J. Running
Mr. Michael J. Running
Regional President AMER
Regional President AMER
1.29K
+105.56%
Mr. Frank Zycinski
Mr. Frank Zycinski
Regional President - EMEA
Regional President - EMEA
723.00
-62.40%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Dean A. Foate
Mr. Dean A. Foate
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
128.06K
+1.57%
Mr. Todd P. Kelsey
Mr. Todd P. Kelsey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
70.15K
+9.25%
Mr. Michael V. (Mike) Schrock
Mr. Michael V. (Mike) Schrock
Lead Independent Director
Lead Independent Director
42.96K
+4.83%
Mr. Patrick John Jermain, CPA
Mr. Patrick John Jermain, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
23.97K
+6.31%
Dr. Joann M. Eisenhart, Ph.D.
Dr. Joann M. Eisenhart, Ph.D.
Independent Director
Independent Director
20.34K
+10.78%
Mr. Paul A. Rooke
Mr. Paul A. Rooke
Independent Director
Independent Director
14.62K
+15.65%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Healthcare/Life Sciences
410.64M
41.89%
Industrial
397.01M
40.50%
Aerospace/Defense
172.52M
17.60%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Healthcare/Life Sciences
410.64M
41.89%
Industrial
397.01M
40.50%
Aerospace/Defense
172.52M
17.60%
Shareholding Stats
Updated: Sat, Nov 15
Updated: Sat, Nov 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.91%
The Vanguard Group, Inc.
13.74%
Disciplined Growth Investors, Inc.
5.80%
Dimensional Fund Advisors, L.P.
5.10%
Fiduciary Management, Inc.
5.05%
Other
56.40%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.91%
The Vanguard Group, Inc.
13.74%
Disciplined Growth Investors, Inc.
5.80%
Dimensional Fund Advisors, L.P.
5.10%
Fiduciary Management, Inc.
5.05%
Other
56.40%
Shareholder Types
Shareholders
Proportion
Investment Advisor
66.20%
Investment Advisor/Hedge Fund
28.06%
Hedge Fund
3.32%
Pension Fund
1.69%
Individual Investor
1.59%
Research Firm
1.46%
Bank and Trust
0.49%
Sovereign Wealth Fund
0.21%
Family Office
0.06%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
601
26.96M
99.91%
-635.56K
2025Q2
610
27.34M
101.32%
-1.31M
2025Q1
612
27.49M
101.46%
-1.27M
2024Q4
592
28.01M
103.57%
-167.53K
2024Q3
549
27.63M
101.47%
-1.11M
2024Q2
526
27.62M
100.87%
-1.59M
2024Q1
531
27.95M
101.23%
-1.21M
2023Q4
523
27.88M
101.36%
-1.05M
2023Q3
522
27.62M
100.51%
-1.69M
2023Q2
506
27.63M
99.92%
-1.60M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
3.79M
14.04%
-143.79K
-3.66%
Jun 30, 2025
The Vanguard Group, Inc.
3.66M
13.54%
+22.89K
+0.63%
Jun 30, 2025
Disciplined Growth Investors, Inc.
1.65M
6.1%
-4.80K
-0.29%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.37M
5.09%
-41.14K
-2.91%
Jun 30, 2025
Fiduciary Management, Inc.
934.34K
3.46%
-3.61K
-0.38%
Jun 30, 2025
American Century Investment Management, Inc.
765.77K
2.84%
+87.55K
+12.91%
Jun 30, 2025
State Street Investment Management (US)
1.06M
3.93%
+24.11K
+2.33%
Jun 30, 2025
BNP Paribas Asset Management USA, Inc.
879.74K
3.26%
-95.87K
-9.83%
Jun 30, 2025
EARNEST Partners, LLC
746.77K
2.77%
+2.24K
+0.30%
Jun 30, 2025
Geode Capital Management, L.L.C.
664.07K
2.46%
-3.58K
-0.54%
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
SRH US Quality GARP ETF
1.78%
Invesco S&P SmallCap Information Technology ETF
1.78%
Invesco S&P SmallCap Quality ETF
1%
Cambria Value and Momentum ETF
0.84%
JPMorgan Active Small Cap Value ETF
0.79%
Avantis US Small Cap Value ETF
0.59%
Franklin US Small Cap Multifactor Index ETF
0.5%
JPMorgan Fundamental Data Science Small Core ETF
0.45%
Fidelity Enhanced Small Cap ETF
0.45%
iShares US Small Cap Value Factor ETF
0.41%
View more
SRH US Quality GARP ETF
Proportion1.78%
Invesco S&P SmallCap Information Technology ETF
Proportion1.78%
Invesco S&P SmallCap Quality ETF
Proportion1%
Cambria Value and Momentum ETF
Proportion0.84%
JPMorgan Active Small Cap Value ETF
Proportion0.79%
Avantis US Small Cap Value ETF
Proportion0.59%
Franklin US Small Cap Multifactor Index ETF
Proportion0.5%
JPMorgan Fundamental Data Science Small Core ETF
Proportion0.45%
Fidelity Enhanced Small Cap ETF
Proportion0.45%
iShares US Small Cap Value Factor ETF
Proportion0.41%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Plexus Corp?
The top five shareholders of Plexus Corp are:
BlackRock Institutional Trust Company, N.A. holds 3.79M shares, accounting for 14.04% of the total shares.
The Vanguard Group, Inc. holds 3.66M shares, accounting for 13.54% of the total shares.
Disciplined Growth Investors, Inc. holds 1.65M shares, accounting for 6.10% of the total shares.
Dimensional Fund Advisors, L.P. holds 1.37M shares, accounting for 5.09% of the total shares.
Fiduciary Management, Inc. holds 934.34K shares, accounting for 3.46% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 3.79M shares, accounting for 14.04% of the total shares.
The Vanguard Group, Inc. holds 3.66M shares, accounting for 13.54% of the total shares.
Disciplined Growth Investors, Inc. holds 1.65M shares, accounting for 6.10% of the total shares.
Dimensional Fund Advisors, L.P. holds 1.37M shares, accounting for 5.09% of the total shares.
Fiduciary Management, Inc. holds 934.34K shares, accounting for 3.46% of the total shares.
What are the top three shareholder types of Plexus Corp?
The top three shareholder types of Plexus Corp are:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Disciplined Growth Investors, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Disciplined Growth Investors, Inc.
How many institutions hold shares of Plexus Corp (PLXS)?
As of 2025Q3, 601 institutions hold shares of Plexus Corp, with a combined market value of approximately 26.96M, accounting for 99.91% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -1.41%.
What is the biggest source of revenue for Plexus Corp?
In FY2025Q2, the Healthcare/Life Sciences business generated the highest revenue for Plexus Corp, amounting to 410.64M and accounting for 41.89% of total revenue.
